125 related articles for article (PubMed ID: 37733028)
21. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
[TBL] [Abstract][Full Text] [Related]
22. p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis.
Parra-Herran C; Bassiouny D; Lerner-Ellis J; Olkhov-Mitsel E; Ismiil N; Hogen L; Vicus D; Nofech-Mozes S
Am J Surg Pathol; 2019 Dec; 43(12):1591-1599. PubMed ID: 31335355
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status.
de Freitas D; Aguiar FN; Anton C; de Almeida DC; Bacchi CE; Carvalho JP; Carvalho FM
Heliyon; 2023 Jun; 9(6):e17495. PubMed ID: 37408903
[TBL] [Abstract][Full Text] [Related]
24. MELF pattern of myometrial invasion and role in possible endometrial cancer diagnostic pathway: A systematic review of the literature.
Prodromidou A; Vorgias G; Bakogiannis K; Kalinoglou N; Iavazzo C
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():147-152. PubMed ID: 30286364
[TBL] [Abstract][Full Text] [Related]
25. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Ultrasound Characteristics of the Microcystic Elongated and Fragmented (MELF) Pattern in Endometrial Cancer According to the International Endometrial Tumor Analysis (IETA) criteria.
Eriksson LSE; Nastic D; Frühauf F; Fischerova D; Nemejcova K; Bono F; Franchi D; Fruscio R; Ghioni M; Haak LA; Hejda V; Meskauskas R; Opolskiene G; Pascual MA; Testa A; Tresserra F; Zannoni GF; Carlson JW; Epstein E
Int J Gynecol Cancer; 2019 Jan; 29(1):119-125. PubMed ID: 30640693
[TBL] [Abstract][Full Text] [Related]
27. Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance.
Espinosa I; Serrat N; Zannoni GF; Rovira R; D'Angelo E; Prat J
Hum Pathol; 2017 Dec; 70():6-13. PubMed ID: 28601659
[TBL] [Abstract][Full Text] [Related]
28. [Microcystic, elongated and fragmented invasive pattern in endometrial adenocarcinoma: a clinicopathologic analysis of 72 cases].
Hu D; Zhang HJ; Shen WC; Zhu WF; Li L; Lin XD; Lu JP; Zheng XW; Wang C; Zhou XR
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):318-322. PubMed ID: 28468037
[No Abstract] [Full Text] [Related]
29. Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Parra-Herran C; Lerner-Ellis J; Xu B; Khalouei S; Bassiouny D; Cesari M; Ismiil N; Nofech-Mozes S
Mod Pathol; 2017 Dec; 30(12):1748-1759. PubMed ID: 28776572
[TBL] [Abstract][Full Text] [Related]
30. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
31. MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
Sanci M; Güngördük K; Gülseren V; Karadeniz T; Kocaer M; Gungorduk O; Özdemir İA
Int J Gynecol Pathol; 2018 Jan; 37(1):17-21. PubMed ID: 28319574
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of a droplet digital PCR assay for detecting
Kim G; Lee SK; Suh DH; Kim K; No JH; Kim YB; Kim H
J Gynecol Oncol; 2022 Mar; 33(2):e15. PubMed ID: 34910396
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India.
Rekhi B; Menon S; Deodhar KK; Ghosh J; Chopra S; Maheshwari A
Ann Diagn Pathol; 2020 Aug; 47():151558. PubMed ID: 32619922
[TBL] [Abstract][Full Text] [Related]
34. Usual-Type Endocervical Adenocarcinoma with a Microcystic, Elongated, and Fragmented Pattern of Stromal Invasion: A Case Report with Emphasis on Ki-67 Immunostaining and Targeted Sequencing Results.
Choi S; Hwang S; Do SI; Kim HS
Case Rep Oncol; 2020; 13(3):1421-1429. PubMed ID: 33442366
[TBL] [Abstract][Full Text] [Related]
35. [Clinical application of TCGA molecular classification in endometrial endometrioid carcinoma].
Du NN; Liu Y; Ren CX; Wang YX; Du J; Yang J; Liu CR
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):596-603. PubMed ID: 31422589
[No Abstract] [Full Text] [Related]
36. Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.
Van Gool IC; Ubachs JEH; Stelloo E; de Kroon CD; Goeman JJ; Smit VTHBM; Creutzberg CL; Bosse T
Histopathology; 2018 Jan; 72(2):248-258. PubMed ID: 28795426
[TBL] [Abstract][Full Text] [Related]
37. [MELF pattern in myometrial infiltration in endometrioid adenocarcinoma of the endometrium. A retrospective study of 70 cases].
Tresserra F; Pascual MÁ; Arenas M; Blancafort C; Martínez-Lanao MÁ; Rodríguez I; Fábregas R
Rev Esp Patol; 2018; 51(2):77-83. PubMed ID: 29602378
[TBL] [Abstract][Full Text] [Related]
38. Strong expression of PD-L1 in invasive front of MELF pattern in endometrioid carcinoma.
Tahara S; Kohara M; Sato K; Morii E
Pathol Res Pract; 2022 Jan; 229():153699. PubMed ID: 34929601
[TBL] [Abstract][Full Text] [Related]
39. Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma.
Ruz-Caracuel I; Ramón-Patino JL; López-Janeiro Á; Yébenes L; Berjón A; Hernández A; Gallego A; Heredia-Soto V; Mendiola M; Redondo A; Peláez-García A; Hardisson D
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766622
[TBL] [Abstract][Full Text] [Related]
40. [Molecular classification and clinicopathological features of endometrial carcinoma].
Li WQ; Shen Y
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):993-999. PubMed ID: 36207912
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]